Panel Hears Final Pleas on Glaxo Diabetes Drug

July 14, 2010

148

Advisers neared a vote on whether a GlaxoSmithKline PLC diabetes drug carries too much heart risk to stay on the market, hearing final conflicting pleas Wednesday from a patient and a public health advocate.

*For more on this story, read the full Reuters article.

Want more from the best local business newspaper in the country?

Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!

Would you like to subscribe to Orange County Business Journal?

One-Year for Only $99

Unlimited access to OCBJ.com
Daily OCBJ Updates delivered via email each weekday morning
Journal issues in both print and digital format
The annual Book of Lists: industry of Orange County's leading companies
Special Features: OC's Wealthiest, OC 500, Best Places to Work, Charity Event Guide, and many more!

Obama Aides Say Stimulus Saved Millions of Jobs

Autos, Gasoline Drag Retail Sales Lower in June

staff-author

Panel Hears Final Pleas on Glaxo Diabetes Drug

Want more from the best local business newspaper in the country?

Would you like to subscribe to Orange County Business Journal?

Featured Articles

(PHOTOS) BioPhotas: The New Face of Light Therapy

Balt’s Irvine HQ Up Close

Inside Shopoff Realty Investment’s Groundbreaking of Bolsa Pacific, the former Westminster Mall

Related Articles

(PHOTOS) BioPhotas: The New Face of Light Therapy

Balt’s Irvine HQ Up Close

Inside Shopoff Realty Investment’s Groundbreaking of Bolsa Pacific, the former Westminster Mall

Inside The $33.5M Sale of 2668 Bayshores Drive in Newport Beach

OC Unemployment Falls to 4.0% in February

Advertise With Us

About Us

Subscriber Links

Other Journals